CMS proposes changes to MA, prescription drug programs
The Centers for Medicare & Medicaid Services late this afternoon released a proposed rule that would make programmatic and operational changes to the Medicare Advantage and prescription drug benefit programs for contract year 2019. According to the agency, the rule would revise program regulations to implement certain provisions of the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act, among other changes. AHA staff are reviewing the rule. Watch for more information.
Related News Articles
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
Analysis projects increases in state uninsured rates following passage of budget reconciliation bill
A KFF analysis published Aug. 20 provides a state-by-state allocation of Congressional Budget Office estimates that 10 million people could be uninsured by…
Headline
A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the…
Headline
The Centers for Medicare & Medicaid Services today announced a nationwide initiative aimed at reinforcing eligibility standards for Medicaid and the…
Headline
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed…
Headline
The U.S. Departments of Labor, Health and Human Services, and the Treasury announced Aug. 7 that they are reconsidering the definition of short-term, limited-…